{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:14:58Z","timestamp":1780910098883,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ24H310011"],"award-info":[{"award-number":["LQ24H310011"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.taap.2025.117606","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:05:32Z","timestamp":1761260732000},"page":"117606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The glutamyl-prolyl-tRNA synthetase 1 inhibitor halofuginone exerts synergistic antitumor effects with bortezomib in colon cancer cells"],"prefix":"10.1016","volume":"506","author":[{"given":"Han","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongchong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaotang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jundixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117606_bb0005","doi-asserted-by":"crossref","first-page":"30405","DOI":"10.3390\/ijms161226238","article-title":"Combination treatment with sublethal ionizing radiation and the proteasome inhibitor, bortezomib, enhances death-receptor mediated apoptosis and anti-tumor immune attack","volume":"16","author":"Cacan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2025.117606_bb0010","doi-asserted-by":"crossref","first-page":"24148","DOI":"10.18632\/oncotarget.4376","article-title":"Halofuginone inhibits colorectal cancer growth through suppression of Akt\/mTORC1 signaling and glucose metabolism","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2025.117606_bb0015","doi-asserted-by":"crossref","first-page":"50302","DOI":"10.18632\/oncotarget.10367","article-title":"Halofuginone and artemisinin synergistically arrest cancer cells at the G1\/G0 phase by upregulating p21Cip1 and p27Kip1","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2025.117606_bb0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2025.117606_bb0025","first-page":"372","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine","volume":"72","author":"Ciardiello","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2025.117606_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18333","article-title":"Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-kappaB inhibition and the induction of oxidative stress","volume":"28","author":"Costa","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2025.117606_bb0035","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s10637-022-01306-7","article-title":"TRIM59 guards ER proteostasis and prevents bortezomib-mediated colorectal cancer (CRC) cells\u2019 killing","volume":"40","author":"Feng","year":"2022","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.taap.2025.117606_bb0040","doi-asserted-by":"crossref","first-page":"177221","DOI":"10.1016\/j.ejphar.2024.177221","article-title":"Experimental study on the inhibitory effect of Halofuginone on NSCLC","volume":"988","author":"Han","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117606_bb0045","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1200\/JCO.23.01337","article-title":"Evidence-based care of older adults with metastatic colorectal cancer: insights from landmark clinical trials","volume":"41","author":"Ioffe","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117606_bb0050","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.21.02691","article-title":"Mismatch repair-deficient colorectal Cancer: building on checkpoint blockade","volume":"40","author":"Jin","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117606_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101203","article-title":"Disease-associated mutations in a bifunctional aminoacyl-tRNA synthetase gene elicit the integrated stress response","volume":"297","author":"Jin","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2025.117606_bb0060","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.kint.2024.01.011","article-title":"Glutamyl-prolyl-tRNA synthetase (EPRS1) drives tubulointerstitial nephritis-induced fibrosis by enhancing T cell proliferation and activity","volume":"105","author":"Kang","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2025.117606_bb0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nchembio.790","article-title":"Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase","volume":"8","author":"Keller","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.taap.2025.117606_bb0070","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1073\/pnas.1913788117","article-title":"Aminoacyl-tRNA synthetase inhibition activates a pathway that branches from the canonical amino acid response in mammalian cells","volume":"117","author":"Kim","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2025.117606_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41408-023-00787-w","article-title":"Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma","volume":"13","author":"Kurata","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.taap.2025.117606_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115504","article-title":"Insight into bortezomib focusing on its efficacy against P-gp-positive MDR Leukemia cells","volume":"22","author":"Kyca","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2025.117606_bb0085","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/s12276-023-01094-x","article-title":"Phosphocode-dependent glutamyl-prolyl-tRNA synthetase 1 signaling in immunity, metabolism, and disease","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.taap.2025.117606_bb0090","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1365-2141.2012.09120.x","article-title":"Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents","volume":"157","author":"Leiba","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.taap.2025.117606_bb0095","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.7150\/ijbs.26776","article-title":"Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production and ER stress in pancreatic cancer cells","volume":"14","author":"Li","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2025.117606_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12929-021-00769-9","article-title":"Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells","volume":"28","author":"Liang","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.taap.2025.117606_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155670","article-title":"The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy","volume":"129","author":"Mi","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2025.117606_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106924","article-title":"Chromatin factors: ready to roll as biomarkers in metastatic colorectal cancer?","volume":"196","author":"Moreta-Moraleda","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2025.117606_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00210-022-02305-4","article-title":"Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress-induced cell death","volume":"396","author":"Naradun","year":"2023","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.taap.2025.117606_bb0120","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-22-2747","article-title":"Dysregulation and epigenetic reprogramming of NRF2 signaling axis promote Acquisition of Cisplatin resistance and metastasis in head and neck squamous cell carcinoma","volume":"29","author":"Osman","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2025.117606_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2022.05.017","article-title":"Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity","volume":"187","author":"Panda","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2025.117606_bb0130","article-title":"Potential applications of NRF2 modulators in cancer therapy","volume":"9","author":"Panieri","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.taap.2025.117606_bb0135","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109985","article-title":"Cellular responses to halofuginone reveal a vulnerability of the GCN2 branch of the integrated stress response","volume":"41","author":"Pitera","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.taap.2025.117606_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177935","article-title":"Brusatol modulates the Nrf2\/GCLC pathway to enhance ferroptosis in the treatment of oral squamous cell carcinoma","volume":"1003","author":"Qi","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117606_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102122","article-title":"Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis","volume":"46","author":"Ren","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.taap.2025.117606_bb0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.21037\/jgo-23-247","article-title":"Identification of glutamyl-prolyl-tRNA synthetase as a new therapeutic target in hepatocellular carcinoma via a novel bioinformatic approach","volume":"14","author":"Shu","year":"2023","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.taap.2025.117606_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12185-023-03705-9","article-title":"Acute accumulation of PIM2 and NRF2 and recovery of beta5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors","volume":"119","author":"Sogabe","year":"2024","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.taap.2025.117606_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123125","article-title":"Bortezomib in cancer therapy: mechanisms, side effects, and future proteasome inhibitors","volume":"358","author":"Sogbein","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2025.117606_bb0165","article-title":"Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy","volume":"5","author":"St Paul","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.taap.2025.117606_bb0170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2016.12.041","article-title":"Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation","volume":"103","author":"Tsuchida","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2025.117606_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102488","article-title":"The predictive role of ERBB2 point mutations in metastatic colorectal cancer: a systematic review","volume":"112","author":"Vaghi","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.taap.2025.117606_bb0180","article-title":"Halofuginone inhibits tumor migration and invasion by affecting cancer-associated fibroblasts in oral squamous cell carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2025.117606_bb0185","article-title":"Targeting c-Myc transactivation by LMNA inhibits tRNA processing essential for malate-aspartate shuttle and tumour progression","volume":"14","author":"Wang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.taap.2025.117606_bb0190","doi-asserted-by":"crossref","first-page":"43697","DOI":"10.1021\/acsomega.4c06152","article-title":"ML385, an Nrf2 inhibitor, synergically enhanced Celastrol triggered endoplasmic reticulum stress in lung cancer cells","volume":"9","author":"Xu","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.taap.2025.117606_bb0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.freeradbiomed.2023.03.027","article-title":"Ferroptosis signaling promotes the release of misfolded proteins via exosomes to rescue ER stress in hepatocellular carcinoma","volume":"202","author":"Yang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2025.117606_bb0200","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2147\/DDDT.S149623","article-title":"Halofuginone ameliorates inflammation in severe acute hepatitis B virus (HBV)-infected SD rats through AMPK activation","volume":"11","author":"Zhan","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.taap.2025.117606_bb0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13046-022-02270-z","article-title":"Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.taap.2025.117606_bb0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7150\/ijbs.86160","article-title":"Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells","volume":"20","author":"Zheng","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2025.117606_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-019-0713-x","article-title":"The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo","volume":"12","author":"Zhou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.taap.2025.117606_bb0220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303642121","article-title":"AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer cells","volume":"121","author":"Zin","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:54:12Z","timestamp":1780908852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25003825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"alternative-id":["S0041008X25003825"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117606","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The glutamyl-prolyl-tRNA synthetase 1 inhibitor halofuginone exerts synergistic antitumor effects with bortezomib in colon cancer cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117606"}}